DRRX

DURECT Corporation (DRRX)

About DURECT Corporation (DRRX)

DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.

Details

Daily high

$1.36

Daily low

$1.26

Price at open

$1.30

52 Week High

$3.14

52 Week Low

$0.47

Market cap

40.4M

Dividend yield

0.00%

Volume

86,877

Avg. volume

66,333

P/E ratio

-1.96

DURECT Corporation News